Allegis Investment Advisors’s Novo Nordisk NVO Stock Holding History

Allegis Investment Advisors’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$1.13M	Sell	46,030 -11,684	-20%	-$307K	0.35%	68
2017 Q4	$1.55M	Sell	57,714 -5,134	-8%	-$131K	0.46%	58
2017 Q3	$1.51M	Sell	62,848 -16,158	-20%	-$365K	0.36%	79
2017 Q2	$1.69M	Sell	79,006 -1,398	-2%	-$28.2K	0.43%	74
2017 Q1	$1.38M	Buy	80,404 +10,698	+15%	+$186K	0.36%	82
2016 Q4	$1.25M	Buy	69,706 +11,886	+21%	+$215K	0.39%	75
2016 Q3	$1.2M	Buy	57,820 +3,772	+7%	+$93.5K	0.47%	82
2016 Q2	$1.43M	Buy	54,048 +2,896	+6%	+$79.4K	0.72%	39
2016 Q1	$1.39M	Buy	51,152 +6,632	+15%	+$178K	0.8%	37
2015 Q4	$1.29M	Buy	+44,520	New	+$1.23M	0.72%	33

Other funds holding NVO

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Allegis Investment Advisors's NVO Position: Q1 2018 in Review

Allegis Investment Advisors reduced its Novo Nordisk (NVO) stake by 20% in Q1 2018, selling an estimated $307K and leaving 46,030 shares worth $1.13M. The position accounts for 0.35% of the portfolio, ranked #68.

Allegis Investment Advisors first reported a position in NVO in Q4 2015 and has held it in 10 quarters since. The position peaked at $1.69M in Q2 2017. 553 funds tracked by Wall St. Rank hold NVO as of Q1 2018.

Allegis Investment Advisors held 46,030 shares of Novo Nordisk worth $1.13M as of Q1 2018.
Allegis Investment Advisors sold 11,684 Novo Nordisk shares in Q1 2018, an estimated $307K.
Novo Nordisk made up 0.35% of Allegis Investment Advisors's portfolio in Q1 2018, its #68 holding.
Allegis Investment Advisors first reported a position in Novo Nordisk in Q4 2015 and has held it in 10 quarters since.
Allegis Investment Advisors's Novo Nordisk position peaked at $1.69M in Q2 2017.
553 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2018.

Based on Allegis Investment Advisors's 13F filing for Q1 2018, filed 24 Apr 2018.